Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prevalence and clinical features of Fabry disease in Japanese male patients with diagnosis of hypertrophic cardiomyopathy.

Journal of cardiology - 1 Jan 2017

Kubo Toru, Ochi Yuri, Baba Yuichi, Hirota Takayoshi, Tanioka Katsutoshi, Yamasaki Naohito, Yoshimitsu Makoto, Higuchi Koji, Takenaka Toshihiro, Nakajima Kimiko, Togawa Tadayasu, Tsukimura Takahiro, Sano Shigetoshi, Tei Chuwa, Sakuraba Hitoshi, Kitaoka Hiroaki

Abstract excerpt

BACKGROUND: The prevalence of Fabry disease (FD) in Japanese patients presenting with unexplained left ventricular hypertrophy (LVH) has remained unclear. METHODS: We measured plasma α-galactosidase A activity in 177 men with a diagnosis of hypertrophic cardiomyopathy (HCM) (maximum LV wall thickness ≥15mm). RESULTS: Two patients (1.1%) showed very low α-galactosidase A activity [0.0 and 0.3nmol/hr/ml (normal...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to alpha-Galactosidase
Share to Cardiomyopathy, Hypertrophic

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Echocardiography

Share to Electrocardiography

Share to Fabry Disease

Share to Heart Failure

Share to Hypertrophy, Left Ventricular

Source

Identifiers

PMID: 27554049
DOI: 10.1016/j.jjcc.2016.05.014

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prevalence and clinical features of Fabry disease in Japanese male patients with diagnosis of hypertrophic cardiomyopathy.PMID 27554049Read ↗

Fabry disease in patients with hypertrophic cardiomyopathy: a practical approach to diagnosis.Semantic proximity Read ↗

Prevalence of Anderson-Fabry disease in patients with hypertrophic cardiomyopathy: the European Anderson-Fabry Disease survey.Semantic proximity Read ↗

The Frequency of Fabry Disease in Patients with Cardiac Hypertrophy of Various Phenotypes Including Prominent Papillary Muscle: The TUCARFAB Study in Turkey.Semantic proximity Read ↗

Prevalence of fabry disease in a cohort of 508 unrelated patients with hypertrophic cardiomyopathy.Semantic proximity Read ↗

Prevalence of Fabry disease in female patients with late-onset hypertrophic cardiomyopathy.Semantic proximity Read ↗

Prevalence of Anderson-Fabry disease in male patients with late onset hypertrophic cardiomyopathy.Semantic proximity Read ↗

An atypical variant of Fabry's disease in men with left ventricular hypertrophy.Semantic proximity Read ↗

Late-onset and classic phenotypes of Fabry disease in males with the GLA-Thr410Ala mutation.Semantic proximity Read ↗

High incidence of the cardiac variant of Fabry disease revealed by newborn screening in the Taiwan Chinese population.Semantic proximity Read ↗

Identification of Fabry Disease in a Tertiary Referral Cohort of Patients with Hypertrophic Cardiomyopathy.Semantic proximity Read ↗

Screening for Fabry Disease in patients with unexplained left ventricular hypertrophy.Semantic proximity Read ↗

α-Galactosidase A Genotype N215S Induces a Specific Cardiac Variant of Fabry Disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.